Literature DB >> 2463227

Monoclonal antibodies to epithelial sialomucins recognize epitopes at different cellular sites in adenolymphomas of the parotid gland.

S Zotter1, P C Hageman, A Lossnitzer, J van den Tweel, J Hilkens, W J Mooi, J Hilgers.   

Abstract

Fourteen monoclonal antibodies (MAbs) to epithelial sialomucins were studied for their immunohistochemical reactivity on serial sections of 14 formalin-fixed and paraffin-embedded adenolymphomas of the parotid gland. Two types of reactivity were observed, suggesting different cellular distribution of the corresponding epitopes. Most antibodies reacted with the luminal membrane of the columnar tumor cells (type-A reaction). The other reaction (type B) was observed with the membrane of basal epithelial cells. The antibodies could be ranked according to their tendency to show type-A and/or type-B reactions. MAb Cal was the only one with a pure type-A reaction. A strong tendency to type-A reactivity (with traces of type-B reactions) was observed for the antibodies HMFG-2, M8, E29 and NCRC-II. Several antibodies gave good type-B reactions in addition to strong type-A reactivity (MAbs 126E7, 115G2, 115D8, 140C1, F36/22, 139H2). MAb DF3 showed equally strong reactions with both cell types. A clear-cut preference of the reactions with basal cells was seen with the antibodies HMFG-1 and 115F5. This subclassification of the antibodies is in accordance with epitope mapping data, obtained by conventional blocking studies reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463227     DOI: 10.1002/ijc.2910410809

Source DB:  PubMed          Journal:  Int J Cancer Suppl        ISSN: 0898-6924


  8 in total

1.  Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers.

Authors:  Brigitte Gückel; Christine Rentzsch; Maria-Dorothea Nastke; Alexander Marmé; Ines Gruber; Stefan Stevanović; Simone Kayser; Diethelm Wallwiener
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-22       Impact factor: 4.553

2.  Immunohistochemical distribution of MAM-3 and MAM-6 antigens in developing salivary glands of the human fetus.

Authors:  S K Lee; C Y Lim; J G Chi; K Yamada; M Mori; A Tsubura; S Morii; J Hilgers; M Govindarajan
Journal:  Histochem J       Date:  1991-08

3.  Characterization of the let-653 gene in Caenorhabditis elegans.

Authors:  S J Jones; D L Baillie
Journal:  Mol Gen Genet       Date:  1995-10-25

4.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

5.  Rise and fall of an anti-MUC1 specific antibody.

Authors:  Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

6.  MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate.

Authors:  C F Qu; Y Li; Y J Song; S M A Rizvi; C Raja; D Zhang; J Samra; R Smith; A C Perkins; C Apostolidis; B J Allen
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

7.  Targeted alpha therapy approach to the management of pancreatic cancer.

Authors:  Barry J Allen; Syed M Abbas Rizvi; Chang F Qu; Ross C Smith
Journal:  Cancers (Basel)       Date:  2011-04-01       Impact factor: 6.639

8.  MUC-1 expression in pleomorphic adenomas using two human milk fat globule protein membrane antibodies (HMFG-1 and HMFG-2).

Authors:  Santa Ponce-Bravo; Constantino Ledesma-Montes; Maricela Garcés-Ortíz
Journal:  J Appl Oral Sci       Date:  2015 May-Jun       Impact factor: 2.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.